| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/JCBFM.2009.198 |
| P8608 | Fatcat ID | release_ffsccipgb5bvthd7pe3l564shq |
| P932 | PMC publication ID | 2893568 |
| P698 | PubMed publication ID | 19773802 |
| P5875 | ResearchGate publication ID | 26831056 |
| P50 | author | Matthew T Harting | Q84325326 |
| P2093 | author name string | James C Grotta | |
| Sean I Savitz | |||
| Sushil Sharma | |||
| Charles S Cox | |||
| Jarek Aronowski | |||
| Roger Strong | |||
| Miranda Brenneman | |||
| P2860 | cites work | Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect | Q24635138 |
| Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats | Q28209989 | ||
| Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 | ||
| Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia | Q33322707 | ||
| Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function | Q33326506 | ||
| Anti-inflammatory effects of human cord blood cells in a rat model of stroke | Q34469782 | ||
| Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia | Q35652254 | ||
| Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats | Q36888097 | ||
| Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines | Q40783492 | ||
| Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure | Q44411377 | ||
| A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats | Q44829964 | ||
| Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume | Q45025359 | ||
| Immunophenotype characterization of rat mesenchymal stromal cells | Q47767426 | ||
| One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke | Q48156405 | ||
| Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis | Q48910741 | ||
| Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats | Q48951431 | ||
| Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. | Q53628210 | ||
| CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury | Q73503153 | ||
| Autologous mesenchymal stem cell transplantation in stroke patients | Q81803888 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 140-149 | |
| P577 | publication date | 2009-09-23 | |
| P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
| P1476 | title | Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats | |
| P478 | volume | 30 |
| Q44268910 | 70th Birthday symposium of Prof. Dr. Riederer: autologous adult stem cells in ischemic and traumatic CNS disorders |
| Q41997884 | A clinical study of autologous bone marrow mononuclear cells for cerebral palsy patients: a new frontier. |
| Q60048500 | Administration of Bone Marrow-Derived Mononuclear Cells Contributed to the Reduction of Hypoxic-Ischemic Brain Injury in Neonatal Rats |
| Q33936887 | Are bone marrow regenerative cells ideal seed cells for the treatment of cerebral ischemia? |
| Q41894963 | Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits |
| Q36301669 | Autologous Bone Marrow Mononuclear Cells Exert Broad Effects on Short- and Long-Term Biological and Functional Outcomes in Rodents with Intracerebral Hemorrhage |
| Q42725512 | Autologous bone marrow mononuclear cells therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury |
| Q36289684 | Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study |
| Q37536181 | Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke |
| Q28308195 | Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia |
| Q34360213 | Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis |
| Q41970966 | Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke |
| Q59337030 | Bone marrow-derived mononuclear cell therapy can attenuate systemic inflammation in rat heatstroke |
| Q37447090 | Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats |
| Q28254272 | CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice |
| Q38109608 | Cell therapies: careful translation from animals to patients |
| Q64063294 | Cell-Based Therapies for Stroke: Promising Solution or Dead End? Mesenchymal Stem Cells and Comorbidities in Preclinical Stroke Research |
| Q38101938 | Clinical significance of metallothioneins in cell therapy and nanomedicine |
| Q42043958 | Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia |
| Q39138693 | Concise Review: Increasing the Validity of Cerebrovascular Disease Models and Experimental Methods for Translational Stem Cell Research |
| Q37049533 | Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model |
| Q34432396 | Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice |
| Q55239568 | Diabetic Ephrin-B2-Stimulated Peripheral Blood Mononuclear Cells Enhance Poststroke Recovery in Mice. |
| Q34408378 | Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy. |
| Q41950578 | Effect of Intravenous Infusion of G-CSF-Mobilized Peripheral Blood Mononuclear Cells on Upper Extremity Function in Cerebral Palsy Children. |
| Q33577748 | Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model |
| Q92417898 | Efficacy of stem cell-based therapies for stroke |
| Q35024757 | Enhanced recovery from chronic ischemic injury by bone marrow cells in a rat model of ischemic stroke |
| Q35577615 | Failure of intravenous or intracardiac delivery of mesenchymal stromal cells to improve outcomes after focal traumatic brain injury in the female rat. |
| Q34630942 | Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats |
| Q36615851 | Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model |
| Q34392864 | Impact of age on the efficacy of bone marrow mononuclear cell transplantation in experimental stroke |
| Q55380020 | In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation. |
| Q37150563 | Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials |
| Q90074677 | Influence of Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Oxidative Stress Intensity in Minimally Conscious State Patients |
| Q88401090 | Intra-Arterial Delivery of Cell Therapies for Stroke |
| Q35663793 | Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms |
| Q36024051 | Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer's Disease Mouse Model |
| Q53082672 | Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial. |
| Q48144302 | Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial |
| Q42152041 | Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. |
| Q35396013 | Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats |
| Q33771764 | Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes |
| Q37587747 | Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia |
| Q33687659 | Intracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia |
| Q58047465 | Intracranial transplantation of monocyte-derived multipotential cells enhances recovery after ischemic stroke in rats |
| Q37239846 | Intrathecal Administration of Autologous CD34 Positive Cells in Patients with Past Cerebral Infarction: A Safety Study |
| Q38170033 | Intravascular stem cell transplantation for stroke |
| Q49015926 | Intravenous autologous bone marrow mononuclear cells for ischemic stroke |
| Q42867516 | Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury |
| Q35648103 | Investigational therapies for ischemic stroke: neuroprotection and neurorecovery |
| Q38916628 | Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery? |
| Q42395056 | Ischemic stroke may activate bone marrow mononuclear cells to enhance recovery after stroke |
| Q90296254 | Letter: Safety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow up |
| Q48152415 | MRI assessment of the intra-carotid route for macrophage delivery after transient cerebral ischemia |
| Q46271091 | Mesenchymal Stem Cell Therapy in Ischemic Stroke: A Meta-analysis of Preclinical Studies. |
| Q41995337 | Mesenchymal stem cells repair germinal cells of seminiferous tubules of sterile rats |
| Q38162224 | Microglial responses after ischemic stroke and intracerebral hemorrhage |
| Q48389920 | Minocycline treatment and bone marrow mononuclear cell transplantation after endothelin-1 induced striatal ischemia. |
| Q48161561 | Multipotent Adult Progenitor Cells Enhance Recovery After Stroke by Modulating the Immune Response from the Spleen |
| Q48590080 | Neuroprotection by intravenous transplantation of bone marrow mononuclear cells from 5-fluorouracil pre-treated rats in a model of ischemic stroke |
| Q52690050 | New prospects of mesenchymal stem cells for ameliorating temporal lobe epilepsy. |
| Q34193407 | Nitric oxide facilitates delivery and mediates improved outcome of autologous bone marrow mononuclear cells in a rodent stroke model |
| Q33556222 | Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial |
| Q37439541 | Paracrine Mechanisms of Intravenous Bone Marrow-Derived Mononuclear Stem Cells in Chronic Ischemic Stroke |
| Q38269517 | Post-stroke depression and the aging brain |
| Q37316255 | Postischemic Long-Term Treatment with Qiangli Tianma Duzhong Capsule Improves Brain Functional Recovery via the Improvement of Hemorrheology and the Inhibition of Platelet Aggregation in a Rat Model of Focal Cerebral Ischemia |
| Q92856462 | Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair After Ischemic Stroke |
| Q28269380 | Preconditioning with VEGF Enhances Angiogenic and Neuroprotective Effects of Bone Marrow Mononuclear Cell Transplantation in a Rat Model of Chronic Cerebral Hypoperfusion |
| Q47712203 | Present Status and Future Challenges of New Therapeutic Targets in Preclinical Models of Stroke in Aged Animals with/without Comorbidities |
| Q34207174 | Progenitor cell therapy for the treatment of central nervous system injury: a review of the state of current clinical trials |
| Q52653365 | Randomized Assessment of the Safety and Efficacy of Intra-Arterial Infusion of Autologous Stem Cells in Subacute Ischemic Stroke. |
| Q46490500 | Real-time MRI for precise and predictable intra-arterial stem cell delivery to the central nervous system. |
| Q64912644 | Recovery of fine motor performance after ischemic damage to motor cortex is facilitated by cell therapy in the rhesus monkey. |
| Q47586113 | Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. |
| Q53427471 | Sensory neuron differentiation potential of in utero mesenchymal stem cell transplantation in rat fetuses with spina bifida aperta. |
| Q38903653 | Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration |
| Q39017141 | Stem cell therapies in age-related neurodegenerative diseases and stroke |
| Q34442610 | Stem cell therapies in preclinical models of stroke associated with aging |
| Q34129832 | Stem cell therapy for cerebral ischemia: from basic science to clinical applications |
| Q38055452 | Stem cells as promising therapeutic options for neurological disorders |
| Q30387946 | Systematic Review and Meta-Analysis of Bone Marrow-Derived Mononuclear Cells in Animal Models of Ischemic Stroke |
| Q35404142 | The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study |
| Q48235507 | The effect of transcatheter injections on cell viability and cytokine release of mononuclear cells |
| Q36318376 | The potential benefit of stem cell therapy after stroke: an update |
| Q38139120 | The potential for genetically altered microglia to influence glioma treatment. |
| Q37025630 | The rise of cell therapy trials for stroke: review of published and registered studies |
| Q61806270 | The spleen may be an important target of stem cell therapy for stroke |
| Q42263708 | Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke |
| Q53432517 | Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury. |
| Q45498139 | Transplantation of bone mesenchymal stem cells promotes angiogenesis and improves neurological function after traumatic brain injury in mouse |
| Q48748310 | Transplantation of hematopoietic stem cells: intra-arterial versus intravenous administration impacts stroke outcomes in a murine model |
| Q39228433 | Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells. |
| Q41975448 | Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke Model |
| Q50251827 | Visualization of the Superparamagnetic Iron Oxide (SPIO)-Labeled Bone Marrow Stromal Cells Using a 3.0-T MRI-a Pilot Study for Clinical Testing of Neurotransplantation |
Search more.